Clinical Trial

Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents

Study acronym: DATES
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 28, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-18; most recent amendment 2025-11-26.
Status change: Not Yet Recruiting → Recruiting 2025-11-26
Trial Details
NCT Number NCT07039149
Lead Sponsor Jordan Collaborating Cardiology Group
Conditions Major Bleeding, Major Adverse Cardiovascular and Cerebrovascular Events (MACCE)
Enrollment 200 participants
Start Date 2025-08-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-28